RBC Capital raised the firm’s price target on Legence (LGN) to $64 from $48 and keeps an Outperform rating on the shares after its Q4 results. The momentum remained strong in its second quarter as a public company, with revenue and adjusted EBITDA coming in ahead of estimates, the analyst tells investors in a research note. Building off these results, RBC expects Legence to carry its momentum into 2026 as the company integrates recent acquisitions and positions itself for future M&A, the firm added.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LGN:
